Surface Ophthalmics Revenue and Competitors
Estimated Revenue & Valuation
- Surface Ophthalmics's estimated annual revenue is currently $502.5k per year.
- Surface Ophthalmics's estimated revenue per employee is $100,500
- Surface Ophthalmics's total funding is $36M.
Employee Data
- Surface Ophthalmics has 5 Employees.
- Surface Ophthalmics grew their employee count by -55% last year.
Surface Ophthalmics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
Surface Ophthalmics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $84.8M | 422 | 24% | N/A | N/A |
#2 | $0.4M | 2 | 0% | N/A | N/A |
#3 | $32M | 159 | 3% | N/A | N/A |
#4 | $35M | 121 | 3% | $62.5M | N/A |
#5 | $30.2M | 150 | 18% | N/A | N/A |
#6 | $135.3M | 673 | 0% | N/A | N/A |
#7 | $110.3M | 549 | N/A | N/A | N/A |
#8 | $60.1M | 299 | -4% | N/A | N/A |
#9 | $554.8M | 1725 | 2% | N/A | N/A |
#10 | $10.5M | 52 | 4% | N/A | N/A |
What Is Surface Ophthalmics?
Surface Ophthalmics, Inc. is a pharmaceutical company focused on development and commercialization of innovative therapeutics for ocular diseases. We are striving to solve key patient needs in eye care through leveraging deep expertise, a bold approach, an eye toward efficiency, and a clear, differentiated clinical advantages. Our current drug pipeline consists of three proprietary drug candidates, all utilizing Klarity®, a patented delivery vehicle. We are led by an experienced and proven management team and board of directors with over 80 years of ophthalmology related professional experience.
keywords:N/A
$36M
Total Funding
5
Number of Employees
$502.5k
Revenue (est)
-55%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Surface Ophthalmics News
an ophthalmic-focused healthcare company, today announced that it will ... being developed by Surface Ophthalmics and Melt Pharmaceuticals.
Harrow Health, Inc. (NASDAQ: HROW) is an ophthalmic-focused ... Surface Ophthalmics and Melt Pharmaceuticals, all of which started as Harrow...
Neurostimulation approaches to Ocular Surface Disease have received FDA approvals and have also earned clinical acceptance by patients and...
Other Companies in Pleasanton
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.4M | 5 | 0% | N/A |
#2 | $1.3M | 5 | -29% | N/A |
#3 | $0.4M | 5 | 25% | N/A |
#4 | $0.4M | 5 | 0% | N/A |
#5 | $0.4M | 5 | 0% | N/A |